Sovremennye podkhody k lecheniyu gepatotsellyulyarnoy kartsinomy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

In most countries, morbidity and mortality from primary malignant liver tumors is increased; hepatocellular carcinoma (HCC) is diagnosed among 85 % of patients. Viral hepatitis and liver cirrhosis are main etiological factors for HCC. Diagnosis of the HCC at an early stage only allows to achieve success in the treatment of disease; therefore, all high-risk patients should be screened 2 times a year. Currently, liver resection remains the primary treatment for HCC, which allows to hope for a satisfactory long-term results. Best results of surgical treatment were subject to the Milan criteria. However, HCC is diagnosed at later stages in most patients. Therefore, many hospitals have expanded the indications for surgical treatment of HCC and developed the new treatment strategies in recent years.

Full Text

Restricted Access

References

  1. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ в 2008 г. // Вестник РОНЦ 2010.
  2. Barbara L, Benzi G, Gaiani S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992;16:132.
  3. Okuda H. Hepatocellular carcinoma development in cirrhosis. Res Clin Gastroenterol 2007; 1:161-73.
  4. Kawarad A, Mizumoto R. Cholangiocellular carcinoma of the liver. Am J Surg 1994;3:354-59.
  5. Nagasue N, Kohno H, Chang YC, et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 1993;217:375-84.
  6. Oka H, Kurioka N, Kim N, et al. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990;12:680-87.
  7. Poon RT, Fan ST, Lo CM, et al. Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg 2002;236:602-11.
  8. Zhou XD, Tang ZY, Yang BH, et al. Experience of 1000 patients who underwent hepatecto-my for small hepatocellular carcinoma. Cancer 2001;91:1479-86.
  9. Nathan H, Schulick RD, Choti MA, Pawlik TM. Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 2009;249:799-805.
  10. Esnaola NF, Mirza N, Lauwers GY, et al. Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan. Ann Surg 2003;238(5):711-19.
  11. Grazi GL, Ercolani G, Pierangeli F, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 2001;234(1):71-8.
  12. Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001;234(1):63-70.
  13. Tateishi R, Yoshida H, Shiina S, et al. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut 2005;54(3):419-25.
  14. Capussotti L, Ferrero A, Vigano L, Polastri R, Tabone M. Liver resection for HCC with cirrhosis: Surgical perspectives out of EASL/AASLD guidelines. EJSO 2009;35:11-5.
  15. Minagawa M, Makuuchi M, Takayama T, Ohtomo K. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 2001;233:379-84.
  16. Ikai I, Arii S, Okazaki M, et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res 2007:37:676-91.
  17. Sun C. Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy. J Surg Oncol 2007; 96:37-45.
  18. Kobayashi S, Takahachi S, Kato Y, et al. Surgical treatment of lymph node metastases from hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 2011:18:559-66.
  19. Grazi GL, Cescon M, Ravaioli M, et al. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clini-copathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther 2003;17:119-29.
  20. John AR, Khan S, Mirza DF, et al. Multivariate and univariate analysis of prognostic factors following resection in HCC: the Birmingham experience. Dig Surg 2006;23:103-09.
  21. Teh SH, Christein J, Donohue J, et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: model of end-stage live disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 2005;9:1207-15.
  22. Schwartz M, Roayaie S, Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol 2007;4(7):424-32.
  23. Hasegawa K, Kokudo N, Imamura H, et al. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005;242:252-59.
  24. Ng KK, Vauthey JN, Pawlik TM, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 2005; 12:364-73.
  25. Samuel D, Colombo M, El Serag H. What is ago al. that transplantation should a chievein the contex to irhe patocellular carcinoma? Proceedings of the 2010 International Consensus Conference on Liver transplantation for HCC, 2-4 December 2010, Zurich, Switzerland. 12-19.
  26. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33:1080-86.
  27. Montorsi M, Santambrogio R, Bianchi P, et al. Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg 2005;9:62-7.
  28. Capussotti L, Muratore A, Amisano M, et al. Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival - a European single center experience. EJSO 2005;31,986-93.
  29. Nuzzo G, Giuliante F, Gauzolino R, et al. Liver resections for hepatocellular carcinoma in chronic liver disease: experience in an Italian centre. Eur J Surg Oncol 2007;33:1014-18.
  30. Margarit C, Charc R, Hidalgo G, et al. Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg 2002;26:257-63.
  31. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepat 2012;56:908-43.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies